Tirzepatide Matches Dulaglutide for Cardiovascular Protection With Added Metabolic Benefits: NEJM Dr Riya Dave22 Dec 2025 11:00 AM ISTIn a large randomized trial involving patients with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide was...
FDA Approves Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Dr. Kamal Kant Kohli22 Dec 2025 10:30 AM ISTThe US Food and Drug Administration has approved aficamten (Myqorzo), an allosteric cardiac myosin inhibitor, for adults with symptomatic obstructive...
Dark-Field X-Ray Speeds Up Pneumothorax Detection Without Losing Accuracy: Study Shows Medha Baranwal21 Dec 2025 8:45 PM ISTGermany: Adding dark-field radiography to standard chest X-rays may significantly improve the detection of pneumothorax while markedly shortening...
Abbott gets USFDA clearance for Amplatzer Piccolo Delivery System for premature babies with heart hole Ruchika Sharma21 Dec 2025 3:15 PM ISTAbbott Park: Abbott has announced it has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its Amplatzer Piccolo...
ART Cycles Linked to Slight Increase in Cardiovascular Risk, Suggests Research Medha Baranwal20 Dec 2025 9:15 AM ISTNorway: Researchers have found in a new registry-based study that each additional cycle of assisted reproductive technology was associated with a...
Dapagliflozin vs Empagliflozin Show Similar Clinical Outcomes in HF: JAMA Dr Riya Dave20 Dec 2025 8:45 AM ISTA cohort study in patients with heart failure (HF) found that dapagliflozin and empagliflozin provided comparable clinical outcomes. The authors note...
What are Key Predictors of Bleeding Risk with Long-Term Apixaban in Cancer-Associated VTE? Dr Riya Dave20 Dec 2025 6:45 AM ISTAccording to a new study, among patients receiving extended anticoagulation with apixaban for cancer-associated VTE, four predictors of clinically...
GLP-1 Receptor Agonists Linked to Lower All-Cause Mortality in Hypertrophic Cardiomyopathy: AHJ, December 2025 Study Reveals New Cardiovascular Benefits Dr. Bhumika Maikhuri19 Dec 2025 10:30 AM ISTA recent study found that Glucagon-like peptide-1 (GLP-1) receptor agonist use in hypertrophic cardiomyopathy (HCM) patients with type 2 diabetes...
Lowering blood sugar cuts heart attack risk in people with prediabetes: Lancet Dr. Kamal Kant Kohli19 Dec 2025 10:00 AM ISTLowering blood sugar levels halves the likelihood of serious heart problems in people with prediabetes. According to King's College London research,...
TyG Index Strongly Predicts Subclinical Myocardial Injury, Especially in Diabetes: Study Jacinthlyn Sylvia19 Dec 2025 9:15 AM ISTA new study published in the journal of Cardiovascular Diabetology showed that for the first time, a U-shaped correlation was found between the...
Angina Without Blocked Arteries Carries No Added Heart Attack Risk Over 15 Years: Study Shows Medha Baranwal19 Dec 2025 9:00 AM ISTDenmark: Patients presenting with angina symptoms but without obstructive coronary artery disease may not face the long-term cardiovascular risks...
New Book on Hypertension Launched During The 77th Annual Conference of Cardiology Society Of India Dr. Bhumika Maikhuri18 Dec 2025 12:30 PM ISTAjanta Pharma recently launched its new book "Spectrum of Hypertension: Spotlight on Metoprolol" during the 77th Annual Conference of the Cardiology...
